Amy Emerson

Amy Emerson is the executive director and Director of Clinical Research of MAPS Public Benefit Corporation. She has worked in clinical development and research beginning in 1993 and applies her experience to all facets of MAPS drug development programs.
Amy Emerson

Recent Posts by Author

Towards an Ethos of Equity and Inclusion in the Psychedelic Movement

Preamble: During the Psychedelic Integration Conference at Esalen in March of 2019, about 25 attendees...

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors